サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1268651

動物用CROおよびCDMOの市場規模、シェア、動向分析レポート動物タイプ別（コンパニオン、家畜）、サービスタイプ別（発見、開発）、用途別、地域別、セグメント別予測、2023～2030年

Veterinary CRO and CDMO Market Size, Share & Trends Analysis Report By Animal Type (Companion, Livestock), By Service Type (Discovery, Development), By Application, By Region, and Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
動物用CROおよびCDMOの市場規模、シェア、動向分析レポート動物タイプ別（コンパニオン、家畜）、サービスタイプ別（発見、開発）、用途別、地域別、セグメント別予測、2023～2030年
出版日: 2023年04月11日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

動物用CROおよびCDMOの市場成長と動向：

Grand View Research, Inc.の新しいレポートによると、世界の動物用CROおよびCDMOの市場規模は、予測期間中に8.94%のCAGRを記録し、2030年までに114億2,000万米ドルに達すると予想されています。

この市場は、新興国における専門家による研究・製造受託機関の増加、動物用医薬品開発の主要段階におけるアウトソーシングサービスの採用の増加、大手企業による動物医療投資の増加、新規治療薬に対する需要の増加など、いくつかの要因によって牽引されています。また、コンパニオンアニマルの普及や動物由来の食品需要の増加により、医薬品の大量生産に対するニーズが高まっています。

そのため、第三者である研究開発受託機関（CDMO）や研究開発受託機関（CRO）のネットワークを活用することで、財務リスクを軽減しながら予定通りの生産規模を確保することが有利になります。COVID-19のパンデミックは、特に2020年の間に市場の低迷を招きました。大多数のアウトソーシング受託機関が経験した主な課題は、非新型コロナウイルス医薬品から新型コロナウイルス医薬品（ヒトへの適用をターゲットとする）への膨大なリソース配分シフト、動物用原料・原薬の供給不足、輸送・物流の混乱、ベンダーとの透明性向上の必要性でした。さらに、中断のない、タイムリーで信頼性の高いサプライチェーンの構築など、その他の困難も、動物用医薬品の開発・製造におけるアウトソーシング組織にさらなる複雑さを与えています。

しかし、翌年には、主要企業や委託先が重要な対策を実施したことにより、市場の成長は急速に回復しました。パンデミックは多くの課題を生み出した一方で、コンパニオンアニマルの飼育率の向上やペットのヒューマニゼーション、動物医療費の改善、予後や診断方法に関する世界の動向を背景にした研究開発活動の拡大など、新しい動向も生み出しました。米国ペット用品協会によると、米国におけるペットケア支出は2018年の905億米ドルから2021年には1,236億米ドルに増加しました。これらの要因は、長期的には主要プレイヤーによる研究開発・製造受託機関の雇用をサポートすると予想されます。

動物用CROおよびCDMO市場レポートハイライト：

  • 動物用医薬品業界の主要企業は、信頼性の高いリソースや技術的専門知識など、幅広い能力を持つCROおよびCDMOが提供する包括的なサービスにより、社内製造プロセスよりも受託アウトソーシングを採用しています。
  • 畜産動物セグメントは、食用動物に特化したワクチン、医薬品、感染症診断薬の生産量が多いことから、2022年に業界を支配しました。コンパニオンアニマルセグメントは、予測期間中に最も速いCAGRで成長することが期待されています。
  • 2022年のアニマルヘルスCRO＆CDMO市場では、開発セグメントが最大の収益シェアを獲得しました。一方、探索セグメントは予測期間中に最も速いCAGRを記録すると予測されています。
  • 医薬セグメントは2022年に業界をリードしました。感染症の新たな発生は、新薬の発売に対する多額の支出を伴う獣医学研究開発活動の必要性を高めています。そのため、CROは円滑な発見・開発プロセスに大きく貢献しています。
  • 北米は、主要企業の存在感が強く、同地域における医薬品開発および動物用製品の発売活動の増加も相まって、2022年の主要地域となりました。
  • 主要企業は、業界の存在感を高めるために重要な施策や戦略を実施しています。例えば、2022年10月、動物の健康に特化したCROとCDMOを統合したKlifovet（Argenta Groupの一部）は、西欧と南欧州での足跡を拡大するためにOndax Scientificを買収しました。

目次

第1章 調査手法と範囲

  • 市場セグメンテーションと範囲
    • 推定・予測のタイムライン
  • 調査手法
  • 情報調達
    • 購入したデータベース
    • GVRの内部データベース
    • 二次情報
    • 1次調査
    • 1次調査の詳細
  • 情報またはデータ分析
    • データ分析モデル
  • 市場の形成と検証
  • モデル詳細
    • 商品フロー分析
  • 二次情報のリスト
  • 目的

第2章 エグゼクティブサマリー

  • 市場スナップショット、2022年（100万米ドル）
  • セグメントのスナップショット
  • 競合のスナップショット

第3章 動物用CROおよびCDMO市場：市場変数の動向と範囲

  • 市場系統の見通し
    • 親市場分析
    • 補助的な市場分析
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • 業界分析
    • ポーターのファイブフォース分析
      • 買い手の交渉力
      • 供給企業の交渉力
      • 新規参入業者の脅威
      • 代替品の脅威
      • 業界のライバル関係：高い
    • PESTEL分析
      • 政治的および法的情勢
      • 経済的および社会的情勢
      • 環境情勢
      • テクノロジーの情勢
  • 主要種および主要国別の推定動物個体数、2018～2022年
  • 規制の枠組み
  • 機会分析/アンメットニーズ
  • COVID-19感染症の影響分析

第4章 動物用CROおよびCDMO市場：動物タイプ分析

  • 動物タイプの市場シェア分析、2022年および2030年
  • 動物用CROおよびCDMO市場：動物種の変動分析、2018年から2030年
  • コンパニオンアニマル
  • 家畜

第5章 動物用CROおよびCDMO市場：サービスタイプ分析

  • サービスタイプの市場シェア分析、2022年および2030年
  • 動物用CROおよびCDMO市場：サービスタイプの変動分析、2018年から2030年
  • 発見
  • 開発
    • 初期段階/前臨床
    • 後期/臨床
  • 製造業
  • 包装とラベル貼り
  • 市場承認と市販後

第6章 動物用CROおよびCDMO市場：用途分析

  • 用途の市場シェア分析、2022年および2030年
  • 動物用CROおよびCDMO市場：用途の変動分析、2018年から2030年
  • 薬
    • 医薬品
    • 生物製剤
    • その他
  • 医療機器

第7章 動物用CROおよびCDMO市場：地域市場分析、2018～2030年（100万米ドル）

  • 地域市場シェア分析、2022年および2030年
  • 地域市場のスナップショット
  • 北米
    • SWOT分析：
    • 米国
    • カナダ
  • 欧州
    • SWOT分析：
    • 英国
      • 主要な国の動向
      • 競合シナリオ
    • ドイツ
      • 主要な国の動向
      • 競合シナリオ
    • フランス
      • 主要な国の動向
      • 競合シナリオ
    • イタリア
      • 主要な国の動向
      • 競合シナリオ
    • スペイン
      • 主要な国の動向
      • 競合シナリオ
  • アジア太平洋地域
    • SWOT分析：
    • 日本
      • 主要な国の動向
      • 競合シナリオ
    • 中国
      • 主要な国の動向
      • 競合シナリオ
    • インド
      • 主要な国の動向
      • 競合シナリオ
    • オーストラリア
      • 主要な国の動向
      • 競合シナリオ
    • 韓国
      • 主要な国の動向
      • 競合シナリオ
  • ラテンアメリカ
    • SWOT分析
    • ブラジル
      • 主要な国の動向
      • 競合シナリオ
    • メキシコ
      • 主要な国の動向
      • 競合シナリオ
  • MEA
    • SWOT分析：
    • 南アフリカ
      • 主要な国の動向
      • 競合シナリオ
    • サウジアラビア
      • 主要な国の動向
      • 競合シナリオ

第9章 動物用CROおよびCDMO市場-競合情勢

  • Labcorp Drug Development
  • Charles River Laboratories
  • clinvet
  • KLIFOVET GmbH（Argenta Group）
  • OCR-Oncovet Clinical Research
  • knoell-Triveritas
  • Veterinary Research Management
  • VETSPIN
  • Inotiv.
  • IDEXX Laboratories
  • Zoetis-Nexvet
  • Vetio
  • 参加者の概要
  • 財務実績
  • サービスのベンチマーク
  • 参入企業
  • 戦略マッピング
  • List of Private Players
図表

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of key companies
  • Table 3. North America Veterinary CRO & CDMO market, by country, 2018 - 2030 (USD Million)
  • Table 4. North America Veterinary CRO & CDMO market, by animal type, 2018 - 2030 (USD Million)
  • Table 5. North America Veterinary CRO & CDMO market, by service type, 2018 - 2030 (USD Million)
  • Table 6. North America Veterinary CRO & CDMO service type market, by development, 2018 - 2030 (USD Million)
  • Table 7. North America Veterinary CRO & CDMO market, by application, 2018 - 2030 (USD Million)
  • Table 8. North America Veterinary CRO & CDMO application market, by medicine, 2018 - 2030 (USD Million)
  • Table 9. U.S. Veterinary CRO & CDMO market, by animal type, 2018 - 2030 (USD Million)
  • Table 10. U.S. Veterinary CRO & CDMO market, by service type, 2018 - 2030 (USD Million)
  • Table 11. U.S. Veterinary CRO & CDMO service type market, by development, 2018 - 2030 (USD Million)
  • Table 12. U.S. Veterinary CRO & CDMO market, by application, 2018 - 2030 (USD Million)
  • Table 13. U.S. Veterinary CRO & CDMO application market, by medicine, 2018 - 2030 (USD Million)
  • Table 14. Canada Veterinary CRO & CDMO market, by animal type, 2018 - 2030 (USD Million)
  • Table 15. Canada Veterinary CRO & CDMO market, by service type, 2018 - 2030 (USD Million)
  • Table 16. Canada Veterinary CRO & CDMO service type market, by development, 2018 - 2030 (USD Million)
  • Table 17. Canada Veterinary CRO & CDMO market, by application, 2018 - 2030 (USD Million)
  • Table 18. Canada Veterinary CRO & CDMO application market, by medicine, 2018 - 2030 (USD Million)
  • Table 19. Europe Veterinary CRO & CDMO market, by country, 2018 - 2030 (USD Million)
  • Table 20. Europe Veterinary CRO & CDMO market, by animal type, 2018 - 2030 (USD Million)
  • Table 21. Europe Veterinary CRO & CDMO market, by service type, 2018 - 2030 (USD Million)
  • Table 22. Europe Veterinary CRO & CDMO service type market, by development, 2018 - 2030 (USD Million)
  • Table 23. Europe Veterinary CRO & CDMO market, by application, 2018 - 2030 (USD Million)
  • Table 24. Europe Veterinary CRO & CDMO application market, by medicine, 2018 - 2030 (USD Million)
  • Table 25. U.K. Veterinary CRO & CDMO market, by animal type, 2018 - 2030 (USD Million)
  • Table 26. U.K. Veterinary CRO & CDMO market, by service type, 2018 - 2030 (USD Million)
  • Table 27. U.K. Veterinary CRO & CDMO service type market, by development, 2018 - 2030 (USD Million)
  • Table 28. U.K. Veterinary CRO & CDMO market, by application, 2018 - 2030 (USD Million)
  • Table 29. U.K. Veterinary CRO & CDMO application market, by medicine, 2018 - 2030 (USD Million)
  • Table 30. Germany Veterinary CRO & CDMO market, by animal type, 2018 - 2030 (USD Million)
  • Table 31. Germany Veterinary CRO & CDMO market, by service type, 2018 - 2030 (USD Million)
  • Table 32. Germany Veterinary CRO & CDMO service type market, by development, 2018 - 2030 (USD Million)
  • Table 33. Germany Veterinary CRO & CDMO market, by application, 2018 - 2030 (USD Million)
  • Table 34. Germany Veterinary CRO & CDMO application market, by medicine, 2018 - 2030 (USD Million)
  • Table 35. France Veterinary CRO & CDMO market, by animal type, 2018 - 2030 (USD Million)
  • Table 36. France Veterinary CRO & CDMO market, by service type, 2018 - 2030 (USD Million)
  • Table 37. France Veterinary CRO & CDMO service type market, by development, 2018 - 2030 (USD Million)
  • Table 38. France Veterinary CRO & CDMO market, by application, 2018 - 2030 (USD Million)
  • Table 39. France Veterinary CRO & CDMO application market, by medicine, 2018 - 2030 (USD Million)
  • Table 40. Italy Veterinary CRO & CDMO market, by animal type, 2018 - 2030 (USD Million)
  • Table 41. Italy Veterinary CRO & CDMO market, by service type, 2018 - 2030 (USD Million)
  • Table 42. Italy Veterinary CRO & CDMO service type market, by development, 2018 - 2030 (USD Million)
  • Table 43. Italy Veterinary CRO & CDMO market, by application, 2018 - 2030 (USD Million)
  • Table 44. Italy Veterinary CRO & CDMO application market, by medicine, 2018 - 2030 (USD Million)
  • Table 45. Spain Veterinary CRO & CDMO market, by animal type, 2018 - 2030 (USD Million)
  • Table 46. Spain Veterinary CRO & CDMO market, by service type, 2018 - 2030 (USD Million)
  • Table 47. Spain Veterinary CRO & CDMO service type market, by development, 2018 - 2030 (USD Million)
  • Table 48. Spain Veterinary CRO & CDMO market, by application, 2018 - 2030 (USD Million)
  • Table 49. Spain Veterinary CRO & CDMO application market, by medicine, 2018 - 2030 (USD Million)
  • Table 50. Asia Pacific Veterinary CRO & CDMO market, by country, 2018 - 2030 (USD Million)
  • Table 51. Asia Pacific Veterinary CRO & CDMO market, by animal type, 2018 - 2030 (USD Million)
  • Table 52. Asia Pacific Veterinary CRO & CDMO market, by service type, 2018 - 2030 (USD Million)
  • Table 53. Asia Pacific Veterinary CRO & CDMO service type market, by development, 2018 - 2030 (USD Million)
  • Table 54. Asia Pacific Veterinary CRO & CDMO market, by application, 2018 - 2030 (USD Million)
  • Table 55. Asia Pacific Veterinary CRO & CDMO application market, by medicine, 2018 - 2030 (USD Million)
  • Table 56. Japan Veterinary CRO & CDMO market, by animal type, 2018 - 2030 (USD Million)
  • Table 57. Japan Veterinary CRO & CDMO market, by service type, 2018 - 2030 (USD Million)
  • Table 58. Japan Veterinary CRO & CDMO service type market, by development, 2018 - 2030 (USD Million)
  • Table 59. Japan Veterinary CRO & CDMO market, by application, 2018 - 2030 (USD Million)
  • Table 60. Japan Veterinary CRO & CDMO application market, by medicine, 2018 - 2030 (USD Million)
  • Table 61. China Veterinary CRO & CDMO market, by animal type, 2018 - 2030 (USD Million)
  • Table 62. China Veterinary CRO & CDMO market, by service type, 2018 - 2030 (USD Million)
  • Table 63. China Veterinary CRO & CDMO service type market, by development, 2018 - 2030 (USD Million)
  • Table 64. China Veterinary CRO & CDMO market, by application, 2018 - 2030 (USD Million)
  • Table 65. China Veterinary CRO & CDMO application market, by medicine, 2018 - 2030 (USD Million)
  • Table 66. India Veterinary CRO & CDMO market, by animal type, 2018 - 2030 (USD Million)
  • Table 67. India Veterinary CRO & CDMO market, by service type, 2018 - 2030 (USD Million)
  • Table 68. India Veterinary CRO & CDMO service type market, by development, 2018 - 2030 (USD Million)
  • Table 69. India Veterinary CRO & CDMO market, by application, 2018 - 2030 (USD Million)
  • Table 70. India Veterinary CRO & CDMO application market, by medicine, 2018 - 2030 (USD Million)
  • Table 71. Australia Veterinary CRO & CDMO market, by animal type, 2018 - 2030 (USD Million)
  • Table 72. Australia Veterinary CRO & CDMO market, by service type, 2018 - 2030 (USD Million)
  • Table 73. Australia Veterinary CRO & CDMO service type market, by development, 2018 - 2030 (USD Million)
  • Table 74. Australia Veterinary CRO & CDMO market, by application, 2018 - 2030 (USD Million)
  • Table 75. Australia Veterinary CRO & CDMO application market, by medicine, 2018 - 2030 (USD Million)
  • Table 76. South Korea Veterinary CRO & CDMO market, by animal type, 2018 - 2030 (USD Million)
  • Table 77. South Korea Veterinary CRO & CDMO market, by service type, 2018 - 2030 (USD Million)
  • Table 78. South Korea Veterinary CRO & CDMO service type market, by development, 2018 - 2030 (USD Million)
  • Table 79. South Korea Veterinary CRO & CDMO market, by application, 2018 - 2030 (USD Million)
  • Table 80. South Korea Veterinary CRO & CDMO application market, by medicine, 2018 - 2030 (USD Million)
  • Table 81. LATAM Veterinary CRO & CDMO market, by country, 2018 - 2030 (USD Million)
  • Table 82. LATAM Veterinary CRO & CDMO market, by animal type, 2018 - 2030 (USD Million)
  • Table 83. LATAM Veterinary CRO & CDMO market, by service type, 2018 - 2030 (USD Million)
  • Table 84. LATAM Veterinary CRO & CDMO service type market, by development, 2018 - 2030 (USD Million)
  • Table 85. LATAM Veterinary CRO & CDMO market, by application, 2018 - 2030 (USD Million)
  • Table 86. LATAM Veterinary CRO & CDMO application market, by medicine, 2018 - 2030 (USD Million)
  • Table 87. Brazil Veterinary CRO & CDMO market, by animal type, 2018 - 2030 (USD Million)
  • Table 88. Brazil Veterinary CRO & CDMO market, by service type, 2018 - 2030 (USD Million)
  • Table 89. Brazil Veterinary CRO & CDMO service type market, by development, 2018 - 2030 (USD Million)
  • Table 90. Brazil Veterinary CRO & CDMO market, by application, 2018 - 2030 (USD Million)
  • Table 91. Brazil Veterinary CRO & CDMO application market, by medicine, 2018 - 2030 (USD Million)
  • Table 92. Mexico Veterinary CRO & CDMO market, by animal type, 2018 - 2030 (USD Million)
  • Table 93. Mexico Veterinary CRO & CDMO market, by service type, 2018 - 2030 (USD Million)
  • Table 94. Mexico Veterinary CRO & CDMO service type market, by development, 2018 - 2030 (USD Million)
  • Table 95. Mexico Veterinary CRO & CDMO market, by application, 2018 - 2030 (USD Million)
  • Table 96. Mexico Veterinary CRO & CDMO application market, by medicine, 2018 - 2030 (USD Million)
  • Table 97. MEA Veterinary CRO & CDMO market, by country, 2018 - 2030 (USD Million)
  • Table 98. MEA Veterinary CRO & CDMO market, by animal type, 2018 - 2030 (USD Million)
  • Table 99. MEA Veterinary CRO & CDMO market, by service type, 2018 - 2030 (USD Million)
  • Table 100. MEA Veterinary CRO & CDMO service type market, by development, 2018 - 2030 (USD Million)
  • Table 101. MEA Veterinary CRO & CDMO market, by application, 2018 - 2030 (USD Million)
  • Table 102. MEA Veterinary CRO & CDMO application market, by medicine, 2018 - 2030 (USD Million)
  • Table 103. South Africa Veterinary CRO & CDMO market, by animal type, 2018 - 2030 (USD Million)
  • Table 104. South Africa Veterinary CRO & CDMO market, by service type, 2018 - 2030 (USD Million)
  • Table 105. South Africa Veterinary CRO & CDMO service type market, by development, 2018 - 2030 (USD Million)
  • Table 106. South Africa Veterinary CRO & CDMO market, by application, 2018 - 2030 (USD Million)
  • Table 107. South Africa Veterinary CRO & CDMO application market, by medicine, 2018 - 2030 (USD Million)
  • Table 108. Saudi Arabia Veterinary CRO & CDMO market, by animal type, 2018 - 2030 (USD Million)
  • Table 109. Saudi Arabia Veterinary CRO & CDMO market, by service type, 2018 - 2030 (USD Million)
  • Table 110. Saudi Arabia Veterinary CRO & CDMO service type market, by development, 2018 - 2030 (USD Million)
  • Table 111. Saudi Arabia Veterinary CRO & CDMO market, by application, 2018 - 2030 (USD Million)
  • Table 112. Saudi Arabia Veterinary CRO & CDMO application market, by medicine, 2018 - 2030 (USD Million)
  • Table 113. Global Veterinary CRO & CDMO market, by region, 2018 - 2030 (USD Million)
  • Table 114. Global Veterinary CRO & CDMO market, by animal type, 2018 - 2030 (USD Million)
  • Table 115. Global Veterinary CRO & CDMO market, by service type, 2018 - 2030 (USD Million)
  • Table 116. Global Veterinary CRO & CDMO service type market, by development, 2018 - 2030 (USD Million)
  • Table 117. Global Veterinary CRO & CDMO market, by application, 2018 - 2030 (USD Million)
  • Table 118. Global Veterinary CRO & CDMO application market, by medicine, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Commodity flow analysis
  • Fig. 10 Penetration & growth prospect mapping
  • Fig. 11 Market trends & outlook
  • Fig. 12 Market driver relevance analysis (Current & future impact)
  • Fig. 13 Market restraint relevance analysis (Current & future impact)
  • Fig. 14 Veterinary CRO & CDMO Market Animal type outlook: Key takeaways, 2022 & 2030
  • Fig. 15 Veterinary CRO & CDMO Market: Animal type movement analysis
  • Fig. 16 Global companion animals market 2018 - 2030 (USD Million)
  • Fig. 17 Global livestock animals market 2018 - 2030 (USD Million)
  • Fig. 18 Veterinary CRO & CDMO Market Service type outlook: Key takeaways, 2022 & 2030
  • Fig. 19 Veterinary CRO & CDMO Market: Service type movement analysis
  • Fig. 20 Global discovery market 2018 - 2030 (USD Million)
  • Fig. 21 Global development animals market 2018 - 2030 (USD Million)
  • Fig. 22 Global early phase/preclinical development market 2018 - 2030 (USD Million)
  • Fig. 23 Global late phase/clinical development market 2018 - 2030 (USD Million)
  • Fig. 24 Global manufacturing market 2018 - 2030 (USD Million)
  • Fig. 25 Global packaging & labeling market 2018 - 2030 (USD Million)
  • Fig. 26 Global market approval & post marketing market 2018 - 2030 (USD Million)
  • Fig. 27 Veterinary CRO & CDMO Market Application outlook: Key takeaways, 2022 & 2030
  • Fig. 28 Veterinary CRO & CDMO Market: Application movement analysis
  • Fig. 29 Global medicine market 2018 - 2030 (USD Million)
  • Fig. 30 Global pharmaceutical medicines market 2018 - 2030 (USD Million)
  • Fig. 31 Global biologic medicines market 2018 - 2030 (USD Million)
  • Fig. 32 Global other medicines market 2018 - 2030 (USD Million)
  • Fig. 33 Global medical devices market 2018 - 2030 (USD Million)
  • Fig. 34 Regional outlook, 2022 & 2030
  • Fig. 35 Regional marketplace: Key takeaways
  • Fig. 36 North America Veterinary CRO & CDMO Market by countries, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. Veterinary CRO & CDMO market, 2018 - 2030 (USD Million)
  • Fig. 38 Canada Veterinary CRO & CDMO market, 2018 - 2030 (USD Million)
  • Fig. 39 Europe Veterinary CRO & CDMO market by countries, 2018 - 2030 (USD Million)
  • Fig. 40 U.K. Veterinary CRO & CDMO market, 2018 - 2030 (USD Million)
  • Fig. 41 Germany Veterinary CRO & CDMO market, 2018 - 2030 (USD Million)
  • Fig. 42 France Veterinary CRO & CDMO market, 2018 - 2030 (USD Million)
  • Fig. 43 Italy Veterinary CRO & CDMO market, 2018 - 2030 (USD Million)
  • Fig. 44 Spain Veterinary CRO & CDMO market, 2018 - 2030 (USD Million)
  • Fig. 45 Asia Pacific Veterinary CRO & CDMO market by countries, 2018 - 2030 (USD Million)
  • Fig. 46 China Veterinary CRO & CDMO market, 2018 - 2030 (USD Million)
  • Fig. 47 Japan Veterinary CRO & CDMO market, 2018 - 2030 (USD Million)
  • Fig. 48 India Veterinary CRO & CDMO market, 2018 - 2030 (USD Million)
  • Fig. 49 Australia Veterinary CRO & CDMO market, 2018 - 2030 (USD Million)
  • Fig. 50 South Korea Veterinary CRO & CDMO market, 2018 - 2030 (USD Million)
  • Fig. 51 Latin America Veterinary CRO & CDMO market by countries, 2018 - 2030 (USD Million)
  • Fig. 52 Brazil Veterinary CRO & CDMO market, 2018 - 2030 (USD Million)
  • Fig. 53 Mexico Veterinary CRO & CDMO market, 2018 - 2030 (USD Million)
  • Fig. 54 MEA Veterinary CRO & CDMO market by countries, 2018 - 2030 (USD Million)
  • Fig. 55 South Africa Veterinary CRO & CDMO market, 2018 - 2030 (USD Million)
  • Fig. 56 Saudi Arabia Veterinary CRO & CDMO market, 2018 - 2030 (USD Million)
  • Fig. 57 Market participant categorization
  • Fig. 58 Company market position analysis
目次
Product Code: GVR-4-68040-053-0

Veterinary CRO And CDMO Market Growth & Trends:

The global veterinary CRO and CDMO market size is expected to reach USD 11.42 billion by 2030, registering a CAGR of 8.94% over the forecast period, according to a new report by Grand View Research, Inc. The market is driven by several factors, including the growing number of expert contract research & manufacturing organizations in developing countries, rising adoption of outsourcing services in key stages of veterinary product developments, increasing animal healthcare investments by major players, and growing demand for novel therapeutic products. In addition, the rising adoption of companion animals and growing demand for animal-derived food products are increasing the need for the mass production of medicines.

Therefore, employing the network of third-party Contract Development & Manufacturing Organizations (CDMO) and Contract Research Organizations (CRO) favors the production scale on time with reduced financial risk. The COVID-19 pandemic caused the market downturn, especially during the year 2020. The primary challenges experienced by the majority of contract outsourcing organizations were enormous resource allocation shifts from non-covid to covid medicines (targeting human applications), supply shortages of veterinary raw materials & APIs, transportation & logistics disruption, and the need for more transparency with the vendors. In addition, other difficulties, such as establishing interruption-free, timely, and reliable supply chains, have added more complexity to outsourcing organizations in developing or manufacturing veterinary products.

However, the market growth quickly recovered the following year with significant measures implemented by key players and contract organizations. While it created numerous challenges, the pandemic also set new trends, such as increased ownership rates of companion animals and pet humanization, coupled with improved animal care expenditure and widened R&D activities in the context of global awareness of prognostic and diagnostic measures. According to the American Pet Products Association, pet care expenditure in the U.S. increased from USD 90.5 billion in 2018 to 123.6 billion in 2021. These factors are anticipated to support the employment of contract research, development, and manufacturing organizations by key players in the long run.

Veterinary CRO And CDMO Market Report Highlights:

  • The key players in the animal health industry are adopting contract outsourcing over in-house manufacturing processes owing to the comprehensive services offered by CROs and CDMOs with extensive capabilities, such as highly reliable resources and technical expertise
  • The livestock animal segment dominated the industry in 2022 owing to the large production rate of vaccines, pharmaceuticals, and infectious disease diagnostic products specifically for food-producing animals. The companion animal segment is expected to grow at the fastest CAGR during the projected period
  • The development segment generated the largest revenue share of the animal health CRO & CDMO market in 2022. Whereas, the discovery segment is anticipated to register the fastest CAGR during the forecast period
  • The medicine segment led the industry in 2022. New outbreaks of infectious diseases are increasing the need for veterinary R&D activities with significant expenditure on novel drug launches. Therefore, CROs are contributing largely to the smooth discovery and development processes
  • North America was the leading region in 2022 due to the strong presence of key players coupled with the increased number of drug development and veterinary product launch activities in the region
  • Key companies are implementing significant measures and strategies to enhance their industry presence. For instance, in October 2022, Klifovet (a part of Argenta Group), a combined CRO and CDMO dedicated to animal health, acquired Ondax Scientific to expand its footprint in Western and Southern Europe

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Estimates & Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary Research
    • 1.3.5 Details of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
  • 1.7 List of Secondary Sources
  • 1.8 Objectives

Chapter 2 Executive Summary

  • 2.1 Market Snapshot, 2022 (USD Million)
  • 2.2 Segment Snapshot
  • 2.3 Competitive Snapshot

Chapter 3 Veterinary CRO & CDMO Market: Market Variables Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Analysis
    • 3.1.2 Ancillary Market Analysis
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
    • 3.2.2 Market Restraint Analysis
  • 3.3 Industry Analysis
    • 3.3.1 Porter's 5 Forces Analysis
      • 3.3.1.1 Bargaining Power Of Buyers
      • 3.3.1.2 Bargaining Power Of Suppliers
      • 3.3.1.3 Threat Of New Entrants
      • 3.3.1.4 Threat Of Substitutes
      • 3.3.1.5 Industry Rivalry: High
    • 3.3.2 Pestel Analysis
      • 3.3.2.1 Political & Legal Landscape
      • 3.3.2.2 Economic & Social Landscape
      • 3.3.2.3 Environmental Landscape
      • 3.3.2.4 Technology Landscape
  • 3.4 Estimated Animal Population, 2018 - 2022, by Key Species & Key Countries
  • 3.5 Regulatory Framework
  • 3.6 Estimated Global Sales by 50 Key Veterinary Medicines, 2018 - 2022
  • 3.7 Opportunity Analysis/Unmet Needs
  • 3.8 COVID-19 Impact Analysis

Chapter 4 Veterinary CRO & CDMO Market: Animal Type Analysis

  • 4.1 Animal Type Market Share Analysis, 2022 & 2030
  • 4.2 Veterinary CRO & CDMO Market: Animal Type Movement Analysis, 2018 to 2030
  • 4.3 Companion Animals
    • 4.3.1 Companion animals market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4 Livestock Animals
    • 4.4.1 Livestock animals market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5 Veterinary CRO & CDMO Market: Service Type Analysis

  • 5.1 Service Type Market Share Analysis, 2022 & 2030
  • 5.2 Veterinary CRO & CDMO Market: Service Type Movement Analysis, 2018 to 2030
  • 5.3 Discovery
    • 5.3.1 Discovery market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4 Development
    • 5.4.1 Development market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.2 Early Phase/Preclinical
      • 5.4.2.1 Early phase/preclinical market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.3 Late Phase/Clinical
      • 5.4.3.1 Late phase/clinical market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5 Manufacturing
    • 5.5.1 Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6 Packaging & Labeling
    • 5.6.1 Packaging & labeling market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.7 Market Approval & Post-marketing
    • 5.7.1 Market approval & post marketing market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6 Veterinary CRO & CDMO Market: Application Analysis

  • 6.1 Application Market Share Analysis, 2022 & 2030
  • 6.2 Veterinary CRO & CDMO Market: Application Movement Analysis, 2018 to 2030
  • 6.3 Medicines
    • 6.3.1 Medicines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.3.2 Pharmaceuticals
      • 6.3.2.1 Pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.3.3 Biologics
      • 6.3.3.1 Biologics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.3.4 Others
      • 6.3.4.1 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.4 Medical Devices
    • 6.4.1 Medical devices market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7 Veterinary CRO & CDMO Market: Regional Market Analysis, 2018 - 2030 (USD Million)

  • 7.1 Regional Market Share Analysis, 2022 & 2030
  • 7.2 Regional Market Snapshot
  • 7.3 North America
    • 7.3.1 SWOT Analysis:
      • 7.3.1.1 North America Veterinary CRO & CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.2 U.S.
      • 7.3.2.1 Key Country Dynamics
      • 7.3.2.2 Competitive Scenario
      • 7.3.2.3 U.S. Veterinary CRO & CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.3 Canada
      • 7.3.3.1 Key Country Dynamics
      • 7.3.3.2 Competitive Scenario
      • 7.3.3.3 Canada Veterinary CRO & CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4 Europe
    • 7.4.1 SWOT Analysis:
      • 7.4.1.1 Europe Veterinary CRO & CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.2 U.K.
      • 7.4.2.1 Key Country Dynamics
      • 7.4.2.2 Competitive Scenario
      • 7.4.2.3 U.K. Veterinary CRO & CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.3 Germany
      • 7.4.3.1 Key Country Dynamics
      • 7.4.3.2 Competitive Scenario
      • 7.4.3.3 Germany Veterinary CRO & CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.4 France
      • 7.4.4.1 Key Country Dynamics
      • 7.4.4.2 Competitive Scenario
      • 7.4.4.3 France Veterinary CRO & CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.5 Italy
      • 7.4.5.1 Key Country Dynamics
      • 7.4.5.2 Competitive Scenario
      • 7.4.5.3 Italy Veterinary CRO & CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.6 Spain
      • 7.4.6.1 Key Country Dynamics
      • 7.4.6.2 Competitive Scenario
      • 7.4.6.3 Spain Veterinary CRO & CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5 Asia Pacific
    • 7.5.1 SWOT Analysis:
      • 7.5.1.1 Asia Pacific Veterinary CRO & CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.2 Japan
      • 7.5.2.1 Key Country Dynamics
      • 7.5.2.2 Competitive Scenario
      • 7.5.2.3 Japan Veterinary CRO & CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.3 China
      • 7.5.3.1 Key Country Dynamics
      • 7.5.3.2 Competitive Scenario
      • 7.5.3.3 China Veterinary CRO & CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.4 India
      • 7.5.4.1 Key Country Dynamics
      • 7.5.4.2 Competitive Scenario
      • 7.5.4.3 India Veterinary CRO & CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.5 Australia
      • 7.5.5.1 Key Country Dynamics
      • 7.5.5.2 Competitive Scenario
      • 7.5.5.3 Australia Veterinary CRO & CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.6 South Korea
      • 7.5.6.1 Key Country Dynamics
      • 7.5.6.2 Competitive Scenario
      • 7.5.6.3 South Korea Veterinary CRO & CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6 Latin America
    • 7.6.1 SWOT Analysis
      • 7.6.1.1 Latin America Veterinary CRO & CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.2 Brazil
      • 7.6.2.1 Key Country Dynamics
      • 7.6.2.2 Competitive Scenario
      • 7.6.2.3 Brazil Veterinary CRO & CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.3 Mexico
      • 7.6.3.1 Key Country Dynamics
      • 7.6.3.2 Competitive Scenario
      • 7.6.3.3 Mexico Veterinary CRO & CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7 MEA
    • 7.7.1 SWOT Analysis:
      • 7.7.1.1 MEA Veterinary CRO & CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.2 South Africa
      • 7.7.2.1 Key Country Dynamics
      • 7.7.2.2 Competitive Scenario
      • 7.7.2.3 South Africa Veterinary CRO & CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.3 Saudi Arabia
      • 7.7.3.1 Key Country Dynamics
      • 7.7.3.2 Competitive Scenario
      • 7.7.3.3 Saudi Arabia Veterinary CRO & CDMO market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9 Veterinary CRO & CDMO Market - Competitive Landscape

  • 9.1. Labcorp Drug Development
  • 9.2. Charles River Laboratories
  • 9.3. clinvet
  • 9.4. KLIFOVET GmbH (Argenta Group)
  • 9.5. OCR - Oncovet Clinical Research
  • 9.6. knoell - Triveritas
  • 9.7. Veterinary Research Management
  • 9.8. VETSPIN
  • 9.9. Inotiv.
  • 9.10. IDEXX Laboratories
  • 9.11. Zoetis - Nexvet
  • 9.12. Vetio
  • 9.13 Participant's Overview
  • 9.14 Financial Performance
  • 9.15 Service Benchmarking
  • 9.16 Participant Categorization
  • 9.17 Strategy Mapping
  • 9.18 List of Private Players